HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inducible nitric oxide synthase in retinal ischemia-reperfusion injury.

Abstract
The purpose of this study was to determine whether inducible nitric oxide synthase (iNOS) was implicated in the pathogenesis of retinal ischemia-reperfusion injury. Semi-quantitative reverse transcription-polymerase chain reaction showed that the level of iNOS mRNA expression was markedly increased in rat retina following transient ischemia, with peak expression at 12 hr after reperfusion (15.7-fold increase over pre-ischemic levels). In situ hybridization showed that iNOS mRNA was expressed by resident retinal cells, most likely glial cells in the innermost retina, and also by the neutrophils that had infiltrated the retina. Intraperitoneal administration of NG-(1-iminoethyl)-L-ornithine (L-NIO), an inhibitor of iNOS, significantly increased the rate of b-wave recovery compared to that of control animals. The values (mean +/- S.E.M.) were 55.0 +/- 4.4% versus 40.1 +/- 5.1% (P < 0.05) at 1 day and 68.6 +/- 6.6% versus 45.8 +/- 3.5% (P < 0.05) at 3 days. This study shows that iNOS mRNA is highly expressed by non-neuronal cells of the inner retina during reperfusion following transient retinal ischemia. It also shows that L-NIO treatment provides some protection against ischemia-reperfusion injury. We suggest that nitric oxide produced by iNOS may mediate retinal ischemia-reperfusion injury.
AuthorsM Hangai, N Yoshimura, K Hiroi, M Mandai, Y Honda
JournalExperimental eye research (Exp Eye Res) Vol. 63 Issue 5 Pg. 501-9 (Nov 1996) ISSN: 0014-4835 [Print] England
PMID8994353 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • N(G)-iminoethylornithine
  • Ornithine
  • Nitric Oxide Synthase
Topics
  • Animals
  • Electroretinography
  • Gene Expression Regulation
  • In Situ Hybridization
  • Male
  • Nitric Oxide Synthase (antagonists & inhibitors, genetics, metabolism)
  • Ornithine (analogs & derivatives, therapeutic use)
  • Polymerase Chain Reaction
  • RNA, Messenger (genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (enzymology, prevention & control)
  • Retina (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: